ECM
SPPI

Everence Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Everence Capital Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-43,400
Closed -$128K – 761
2020
Q2 		$128K Hold
43,400
– – 0.02% 627
2020
Q1 		$101K Buy
43,400
+28,160
+185% +$77.1K 0.01% 587
2019
Q4 		$55K Hold
15,240
– – 0.01% 672
2019
Q3 		$126K Hold
15,240
– – 0.02% 621
2019
Q2 		$131K Hold
15,240
– – 0.02% 614
2019
Q1 		$163K Buy
+15,240
New +$163K 0.03% 580

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Everence Capital Management's SPPI Position: Q3 2020 in Review

Everence Capital Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2020, closing a stake of 43,400 shares — an estimated $128K sold.

Everence Capital Management first reported a position in SPPI in Q1 2019 and held it in 6 quarters. The position peaked at $163K in Q1 2019. 159 funds tracked by Wall St. Rank hold SPPI as of Q3 2020.

  • Everence Capital Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2020 after selling out during the quarter.
  • Everence Capital Management sold 43,400 Spectrum Pharmaceuticals Inc shares in Q3 2020, an estimated $128K.
  • Everence Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q1 2019 and held it in 6 quarters.
  • Everence Capital Management's Spectrum Pharmaceuticals Inc position peaked at $163K in Q1 2019.
  • 159 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2020.

Based on Everence Capital Management's 13F filing for Q3 2020, filed 20 Oct 2020.